Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-08-10
08:10 am
Purchase
13GALX Oncology Holdings Inc.
ALXO
FMR LLC4,280,516
10.522%
1,687,577increase
(+65.08%)
View
2022-06-10
10:14 am
Sale
13GALX Oncology Holdings Inc.
ALXO
WELLINGTON MANAGEMENT GROUP LLP1,128,101
2.77%
-2,600,229decrease
(-69.74%)
View
2022-02-09
09:09 am
Purchase
13GALX Oncology Holdings Inc.
ALXO
FMR LLC2,592,939
6.402%
2,592,939increase
(New Position)
View
2022-02-04
09:12 am
Sale
13GALX Oncology Holdings Inc.
ALXO
WELLINGTON MANAGEMENT GROUP LLP3,728,330
9.21%
-476,797decrease
(-11.34%)
View
2021-09-10
08:54 am
Purchase
13GALX Oncology Holdings Inc.
ALXO
WELLINGTON MANAGEMENT GROUP LLP4,205,127
10.42%
4,205,127increase
(New Position)
View
2021-06-15
12:19 pm
Purchase
13DALX Oncology Holdings Inc.
ALXO
Logos Global Management LP3,156,981
7.9%
76,080increase
(+2.47%)
View
2020-10-01
10:01 am
Purchase
13DALX Oncology Holdings Inc.
ALXO
venBio Global Strategic Fund II L.P.9,799,331
26.9%
9,799,331increase
(New Position)
View
2020-08-25
7:08 pm
Purchase
13DALX Oncology Holdings Inc.
ALXO
Logos Global Management LP3,080,901
8.4%
3,080,901increase
(New Position)
View
2020-07-30
9:53 pm
Purchase
13DALX Oncology Holdings Inc.
ALXO
LSV Associates LLC4,720,990
12.9%
4,720,990increase
(New Position)
View
2020-07-29
4:35 pm
Purchase
13GALX Oncology Holdings Inc.
ALXO
Vivo Capital IX, LLC4,034,522
11.1%
4,034,522increase
(New Position)
View